Not sure what you were expecting, but the trial results have not been released yet and until they are, trading will reflect that. The $5-6 range appears to be the level at which investors are willing to buy before data. Personally, I wouldn’t expect the trial PR tomorrow given NP’s history of over estimating timelines, but this week or early next week seems likely. Amarex and CYDY really needs to put effort into analyzing the information and then producing the best written PR ever from CYDY.